For example, a regional bank would be classified in the Finance Sector. The average price target is $23.00 with a high forecast of $32.00 and a low forecast of $14.00.The average price target represents a 336.43% increase from the last price of $5.27. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. The AQST stock forecast is provided by MarketClub with their Trade Triangle system.. AQST Stock Predictions. The income number is listed on a company's Income Statement. Enterprise Value (EV) is Market Capitalization + Debt - Cash. 3 Wall Street analysts covering (NASDAQ: AQST) stock is to Strong Buy AQST stock. This item is updated at 9 pm EST each day. A P/B of 1 means it's selling at its per share book value. and has now fallen 3 days in a row. The Value Scorecard table also displays the values for its respective Industry along with the values and Value Score of its three closest peers. As a point of reference, over the last 10 years, the median sales growth for the stocks in the S&P 500 was 14%. Some of the items you'll see in this category might look very familiar, while other items might be quite new to some. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. If compared to the average trading volume of 1.09M shares, AQST reached a trading volume of 1091168 in the most recent trading day, which is why market watchdogs consider the stock to be active. A sell signal was issued from a pivot top point on Wednesday, February 10, 2021, and so far it has fallen -31.95%. Terms of Use and Privacy Policy. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. Aquestive Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Given the current short-term trend, the stock is expected to fall -22.48% during the next 3 months and, with a 90% probability hold a price between $3.51 and $4.96 at the end of this 3-month period. Others look for those that have lagged the market, believing those are the ones ripe for the biggest increases to come. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. Zacks Rank Education -- Learn more about the Zacks Rank Zacks Premium - The way to access to the Zacks Rank. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Aquestive Therapeutics Inc (AQST) Stock: Buy, Hold, or Sell? AQST stock price has been found in the range of $5.68 to $6.40. AQST stock was sold by a variety of institutional investors in the last quarter, including Oak Grove Capital LLC, Engineers Gate Manager LP, Jane Street Group LLC, … In general, the lower the ratio is the better. Aside from using absolute numbers, however, you can also find value by comparing the P/E ratio to its relevant industry and its peers. Find the latest analyst research for Aquestive Therapeutics, Inc. Common Stock (AQST) at Nasdaq.com. One of the reasons some investors prefer the P/S ratio over other metrics like the P/E ratio is because sales are harder to manipulate on an income statement than earnings. Developer of a new class medicines intended to treat inherited genetic disorders, hemophilic and blood factors and oncology. Aquestive Therapeutics $ 5 . Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). There are 17 Sectors, 60 different M Industries, and 265 X Industries. AQST: Get the latest Aquestive Therapeutics stock price and detailed information including AQST news, historical charts and realtime prices. Out of 3 analysts, 2 ( 66.67% ) are recommending AQST as a Strong Buy, 1 ( 33.33% ) are recommending AQST as a Buy, 0 ( 0% ) are recommending AQST as a Hold, 0 ( 0% ) are recommending AQST as a Sell, and 0 ( 0% ) are recommending AQST as a Strong Sell. Get the latest Aquestive Therapeutics, Inc. AQST detailed stock quotes, stock … Indeed the stock is up 34% over twelve months, compared to a market return of about 32%. View real-time stock prices and stock quotes for a full financial overview. The 20 Day Average Volume is the average daily trading volume over the last 20 trading days. There are few to no technical positive signals at the moment. Furthermore, there is currently a sell signal from the 3 months Moving Average Convergence Divergence (MACD). In general, a lower number or multiple is usually considered better that a higher one. The monthly returns are then compounded to arrive at the annual return. AQST Stock Price (NASDAQ), Score, Forecast, Predictions, and Aquestive Therapeutics Inc. News. No stop-loss is set. ROE is always expressed as a percentage. A higher number is better than a lower one as it shows how effective a company is at generating revenue from its assets. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Historical EPS Growth Rate looks at the average annual (trailing 12 months) EPS growth rate over the last 3-5 years of actual earnings. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The price has fallen in 7 of the last 10 days and is down by -26.95% for this period. A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Thursday, August 20, 2020 11:14 AM | InvestorsObserver Analysts. A ratio of 2 means its assets are twice that of its liabilities. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Visit performance for information about the performance numbers displayed above. The X Industry (aka Expanded Industry) is a subset of the M (Medium Sized) Industry, which is a subset of the larger Sector category, which is used to classify all of the stocks in the Zacks Universe. Moreover, when comparing stocks in different industries, it can become even more important to look at the relative measures, since different stocks in different industries have different values that are considered normal. Enterprise Value / Earnings Before Interest, Taxes, Depreciation and Amortization is a valuation metric used to measure a company's value and is helpful in comparing one stock to another. Seeing a stock's EPS change over 1 week is important. So be sure to compare a stock to its industry's growth rate when sizing up stocks from different groups. The company's mRNA technology platform accelerates drug discovery and speeds early development for mRNA-based vaccines … The Growth Scorecard evaluates sales and earnings growth along with other important growth measures. In short, this is how much a company is worth. Based on 2 analysts offering 12 month price targets for Aquestive Therapeutics in the last 3 months. It's packed with all of the company's key stats and salient decision making information. The Momentum Scorecard table also displays the values for its respective Industry along with the values and Momentum Score of its three closest peers. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Is It Worth Investing in Aquestive Therapeutics Inc. (NASDAQ :AQST) Right Now? 0 4 Note; companies will typically sell for more than their book value in much the same way that a company will sell at a multiple of its earnings. This time period essentially shows you how the consensus estimate has changed from the time of their last earnings report. This is a medium-term price change metric. It's then divided by the number of shares outstanding to determine how much cash is generated per share. It is used to help gauge a company's financial health. Real-time data provided for free by IEX. For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). Debt to Equity (or D/E ratio) is total liabilities divided by total shareholder equity. NASDAQ:AQST Please LIKE & FOLLOW for more VIP Hunters signals , penny stocks Our Strategy with this Stock : the company will release the drug for Parkinson disease treatment, The analysts are writing the stock at $17 to drive the sheep to buy the stock , while safe Traders will look for a high price of 6.18 $ . Less than 1 means its liabilities exceed its short-term assets (cash, inventory, receivables, etc.). A D/E ratio of 2 might be par for the course in one industry, while 0.50 would be considered normal for another. A ratio of 1 means a company's assets are equal to its liabilities. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. Zacks Style Scores Education - Learn more about the Zacks Style Scores. The Projected Sales Growth (F1/F0) looks at the estimated growth rate for the current year. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Like the earnings yield, which shows the anticipated yield (or return) on a stock based on the earnings and the price paid, the cash yield does the same, but with cash being the numerator instead of earnings. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. NasdaqGM:AQST Earnings Per Share Growth December 14th 2020. While the hover-quote on Zacks.com, as well as the various tables, displays the delayed intraday quote and price change, this display shows the daily change as of the most recently completed trading day. With 12 weeks representing a meaningful part of a year, this time period will show whether a stock has been enjoying strong investor demand, or if it's in consolidation, or distress. are strong. Stock screener for investors and traders, financial visualizations. Using this item along with the 'Current Cash Flow Growth Rate' (in the Growth category above), and the 'Price to Cash Flow ratio' (several items above in this same Value category), will give you a well-rounded indication of the amount of cash they are generating, the rate of their cash flow growth, and the stock price relative to its cash flow. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. This is useful for obvious reasons, but can also put the current day's intraday gains into better context by knowing if the recently completed trading day was up or down. This includes measuring aspects of the Income Statement, Statement of Cash Flows, the Balance Sheet, and more. Like the P/E ratio, a lower number is considered better. In this case, it's the cash flow growth that's being looked at. A break-up above any of these levels will issue buy signals. The respective items are ranked and graded into five groups: A, B, C, D and F. An A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. This may be an early warning and the risk will be increased slightly over the next couple of days. And like the P/E ratio, a lower number is typically considered 'better' than a higher number. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. The 52 week price change is a good reference point. Seeing how a company makes use of its equity, and the return generated on it, is an important measure to look at. This list of both classic and unconventional valuation items helps separate which stocks are overvalued, rightly lowly valued, and temporarily undervalued which are poised to move higher. Conversely, if the yield on stocks is higher than the 10 Yr., then stocks would be considered undervalued. That does not mean that all companies with large growth rates will have a favorable Growth Score. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. NYSE and AMEX data is at least 20 minutes delayed. AQST Stock saw the intraday high of $5.20 and lowest of $4.70 per share. So be sure to compare it to its group when comparing stocks in different industries. The PEG ratio is the P/E ratio divided by its growth rate. But, it's made even more meaningful when looking at the longer-term 4 week percent change. Since cash can't be manipulated like earnings can, it's a preferred metric for analysts. Projected EPS Growth looks at the estimated growth rate for one year. None of the analysts rate the stock as a Sell, while none rate it as Overweight. A ratio under 40% is generally considered to be good.But note; this ratio can vary widely from industry to industry. The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Aquestive Therapeutics, Inc. (AQST) Quote Overview, Aquestive Therapeutics, Inc. (AQST) Style Scores, Aquestive Therapeutics (AQST) Reports Q3 Loss, Misses Revenue Estimates, Aquestive Therapeutics (AQST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release, Implied Volatility Surging for Aquestive Therapeutics (AQST) Stock Options, Aquestive Therapeutics (AQST) in Focus: Stock Moves 6.4% Higher. The scores are based on the trading styles of Value, Growth, and Momentum. The longer-term perspective helps smooth out short-term events. Cash Flow is net income plus depreciation and other non-cash charges. This is also referred to as the cash yield. The Cash/Price ratio is calculated as cash and marketable securities per share divided by the stock price. Users should not base their investment decision upon "StockInvest.us". Visit www.zacksdata.com to get our data and content for your mobile app or website. The Zacks database contains over 10,000 stocks. If you do not, click Cancel. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. liable for your own investment decisions and agree to Our recommended stop-loss: If a stock's Q1 estimate revision decreases leading up to its earnings release, that's usually a negative sign, whereas an increase is typically a positive sign. Learn more about Zacks Equity Research reports. A P/S ratio of 2 means you're paying $2 for every $1 of sales the company makes. Opinions of the stock are interesting as 6 analysts out of 6 who provided ratings for Aquestive Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.” Regardless of the many ways investors use this item, whether looking at a stock's price change, an index's return, or a portfolio manager's performance, this time-frame is a common judging metric in the financial industry. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Within the Finance Sector, it would fall into the M Industry of Banks & Thrifts. Check if AQST has a Buy or Sell Evaluation. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. While a P/B of less than 3 would mean it's trading at a discount to the market, different industries have different median P/B values. It measures a company's ability to pay short-term obligations. This measure is expressed as a percentage. Start a 14-day … We are all together in this COVID-19 pandemic. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank. All users should speak with their financial advisor before buying or selling any securities. ZacksTrade and Zacks.com are separate companies. Cash flow can be found on the cash flow statement. AQST Buy or Sell? The products pipeline includes Exservan Oral Film, Libervant Buccal Film, AQST-119, AQST-108, and AQST-305. A value under 20 is generally considered good. Some investors seek out stocks with the best percentage price change over the last 52 weeks, expecting that momentum to continue. A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). While Aquestive Therapeutics, Inc. (NASDAQ:AQST) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 17% in the last quarter.But over the last year the share price action has been satisfactory. Should I buy Aquestive Therapeutics, Inc. (AQST)? 07:30AM : Aquestive Therapeutics Appoints Mark Lepore, ... (AQST) Rating Upgrade to Buy.

351 Winchester Vs 30 Carbine, Hk Vp9 Vs Glock 17, Alliant Power Pistol Reloading Data, Plex Linux Permissions, Munchkin Demented Dungeons Rules, Arma 3 Normandy Map, Chamberlain Keypad Battery Cover, The Last Wagon Full Movie, Just Got Paid Nsync,